[Evaluation of selected prognostic factors in planning of the treatment of patients with stage I testicular non-seminoma].
The choice of treatment in 72 patients with non-seminomas of the testis in the 1st stage of clinical advancement after orchidectomy has been in the Oncology Center in Warsaw made in connection with factors assessed on microscopic examination of resected testis as prognostically important (infiltration of the tunica albuginea, epididymis and testicular cord, cellular cancer embolisms of blood and lymphatic vessels). In 30 (out of 72) patients with such factors three courses of chemotherapy according to the PVB programme have been applied. 42 (out of 72) patients without such factors have been under observation. All patients are alive. In one patient of the 42 group observed without treatment progression of the disease has been noted on 16th month of the follow up and the treatment according to PVB programme has been applied with complete regression (CR) as result; patient is alive without symptoms of the active disease 28 months since the completion of the treatment. The probability of 48 months survival, calculated according to life tables is 96%.
Madej
G
G
Przychodní Centrum Onkologii, Instytutu im. Marii Skłodowskiej-Curie w Warszawie.
Pawiński
A
A
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy / Q000379:methods*; D010347:Patient Care Planning; D011182:Postoperative Care; D012074:Remission Induction; D013736:Testicular Neoplasms / Q000473:pathology / Q000601:surgery*; D013737:Testis / Q000473:pathology; D014747:Vinblastine / Q000008:administration & dosage
D001761:Bleomycin; D014747:Vinblastine; D002945:Cisplatin
Ocena wybranych czynników prognostycznych w planowaniu leczenia chorych na nienasieniaki jadra w I stopniu zaawansowania.